Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NervTex is a Chinese digital health and medical technology company focused on brain health, especially movement, mood, cognitive, and behavioral disorders. The company develops AI-, video-, and VR-enabled diagnostic and therapeutic products, including software medical devices and digital therapeutic tools for neurology and mental health. Its best-known product is MoDAS, an AI-based movement dysfunction assessment software that has been approved in China and deployed in hospitals. NervTex positions itself as a "digital new medicine" company translating artificial intelligence, virtual reality, and digital engagement into clinical applications. The company appears to operate primarily as a healthtech and SaMD developer rather than a traditional drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NervTex.